Aptevo Therapeutics Inc. Financial Ratios — APVO Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	- -	-85.21	-47.89	-102.37	6.68	-58.2	-66.91	-33.19	-51.67	17.68	-58.96	-119.36	-121.38
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-126.06	- -	- -	- -
Gross Margin (%)	100	64.38	49.61	-24.86	65.82	51.39	- -	100	100	100	- -	- -	- -
EBITDA Margin (%)	-30,993.53	-108.42	-173.19	-644.95	-346.72	-213.62	- -	-605.43	-164.79	-890.82	- -	- -	- -
Operating Margin (%)	-31,385.29	-112.84	-181.84	-678.62	-368.05	-223.98	- -	-638.06	-174.1	-919.75	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	-46.4	- -	- -	- -	7.61	- -	- -
Pretax Margin (%)	-31,374.71	-113.33	-182.55	-1,397.93	-381.31	-232.75	- -	-717.64	-239.25	225.24	- -	- -	- -
Profit Margin (%)	-31,374.71	-112.02	-176.53	-1,125.84	47.57	-232.75	- -	-411.93	-231.51	257.77	- -	- -	- -
Net Income to Common Margin (%)	-31,374.71	-112.02	-176.53	-1,125.84	47.57	-232.75	- -	-411.93	-231.51	257.77	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	- -	- -	- -	18	19	19	23	27	17	10	5	5	5
ST Debt	- -	- -	- -	- -	3	- -	20	5	12	2	- -	1	1
LT Debt	- -	- -	- -	18	16	19	3	22	5	8	5	5	4
Total Debt/EBITDA	- -	- -	- -	-0.29	-0.38	-0.39	-0.6	-1.05	-0.83	-0.34	-0.19	-0.22	-0.18
Net Debt/EBITDA	- -	0.07	0.08	-0.14	-0.24	0.23	-0.19	0.57	1.46	0.69	0.6	0.36	0.83
Total Debt/EBIT	- -	- -	- -	-0.27	-0.35	-0.37	-0.57	-1	-0.78	-0.33	-0.19	-0.22	-0.18
Net Debt/EBIT	- -	0.07	0.08	-0.13	-0.22	0.22	-0.18	0.54	1.39	0.67	0.59	0.35	0.82
EBITDA to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA-CapEx/Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBIT to Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	- -	-143.93	-181.57	-87.82	-62.99	-188.74	-314.21	-346.54	-378.11	-602.04	-899.23	-1,587.41	-1,011.26
Long-Term Debt/Equity (%)	- -	- -	- -	36.35	19.17	63.4	28.09	135.07	415.13	41.92	44.16	97.35	21.65
Long-Term Debt/Capital (%)	- -	- -	- -	-29.51	-28.79	-17.83	-2.3	-14.17	-2.56	-3.84	-2.48	-1.91	-1.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	20.01	13.44	28.56	6.23	41.86	8.92	22.02	21.73	29.69	13.84
Total Debt/Equity (%)	- -	- -	- -	36.35	23.24	63.4	195.83	165.2	1,374.59	53.05	44.16	113.5	26.63
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt/Total Assets (%)	- -	- -	- -	20.01	16.29	28.56	43.42	51.2	29.53	27.87	21.73	34.62	17.02
Net Debt to Equity	- -	-3.8	-5.23	17.22	14.59	-37.35	62.62	-89.94	-2,439.97	-106.7	-138.32	-183.26	-124.38
Net Debt/Capital (%)	- -	2.04	1.96	-12.1	-19.38	8.19	-4.72	7.53	12.24	8.75	7.2	3.47	7.4
EBITDA	-53	-49	-58	-64	-51	-49	-39	-26	-20	-28	-28	-24	-26
EBITDA-CapEx	-54	-50	-60	-67	-52	-50	-39	-26	-21	-28	-28	-24	-26
Operating Income (Loss)	-53	-51	-61	-68	-54	-52	-41	-27	-21	-29	-29	-25	-26

Liquidity (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	- -	0.18	0.23	2.79	4.36	1.74	0.33	2.75	1.3	2.6	2.34	1.4	3.57
Current Ratio	- -	2.09	1.76	3.65	5.14	2.76	0.78	3.25	1.51	3.15	2.64	1.72	3.82
Quick Ratio	- -	0.94	0.63	2.81	4.48	2.04	0.33	2.91	1.4	2.89	2.34	1.4	3.57
CFO/Avg Current Liab	- -	-4.74	-2.45	-1.87	-2.18	-2.85	-1.52	-1.11	-0.88	-0.97	-1.47	-3.54	-4.18
Common Equity/Total Assets	- -	-143.93	-181.57	-87.82	-62.99	-188.74	-314.21	-346.54	-378.11	-602.04	-899.23	-1,587.41	-1,011.26
Long-Term Debt/Equity (%)	- -	- -	- -	36.35	19.17	63.4	28.09	135.07	415.13	41.92	44.16	97.35	21.65
Long-Term Debt/Capital (%)	- -	- -	- -	-29.51	-28.79	-17.83	-2.3	-14.17	-2.56	-3.84	-2.48	-1.91	-1.39
Long-Term Debt/Total Assets (%)	- -	- -	- -	20.01	13.44	28.56	6.23	41.86	8.92	22.02	21.73	29.69	13.84
Total Debt/Equity (%)	- -	- -	- -	36.35	23.24	63.4	195.83	165.2	1,374.59	53.05	44.16	113.5	26.63
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt/Total Assets (%)	- -	- -	- -	20.01	16.29	28.56	43.42	51.2	29.53	27.87	21.73	34.62	17.02
CFO/Total Liabilities	- -	-185.34	-124.55	-89.27	-118.88	-138.65	-101.97	-79.34	-39.14	-129.44	-92.94	-219.5	-260.8
CFO/CapEx	-50.33	-47.53	-31.93	-14.67	-29.65	-52.69	-277.01	-333.16	-30.41	-724.9	- -	- -	- -
Altman's Z-Score	- -	-7.6	-12.07	-3.08	-1.51	-4.62	-7.74	-5.6	-5.93	-10.41	-15.85	-27.08	-16.42

Working Capital (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	- -	6.6	3.31	2.95	11.98	6.27	- -	1.23	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	55.27	110.13	123.61	30.48	58.24	- -	297.4	- -	- -	- -	- -	- -
Inventory Turnover	- -	1.84	0.89	1.2	6.73	7.97	5.03	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	197.89	408.98	304.23	54.24	45.78	72.57	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	5.91	1.82	-1.47	1.52	1.26	1.96	-0.94	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	61.8	200.41	-248.9	240.52	289.98	185.75	-387.74	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	191.37	318.7	676.74	-155.8	-185.96	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	-142.62	-298.86	-180.62	-23.76	12.46	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	18	20	- -	1	2	6	- -	- -	- -	- -	- -	- -
Raw Materials	- -	8	7	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	3	5	- -	- -	1	2	- -	- -	- -	- -	- -	- -
Finished Goods	- -	6	9	- -	- -	1	4	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	2	4	1	1	8	2	1	- -	- -	3
- Cash & Cash Equivalents	- -	4	5	10	7	31	12	40	45	23	17	9	22
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	18	19	19	23	27	17	10	5	5	5
Enterprise Value	- -	-4	-5	-34	-58	-10	12	-4	-26	-12	-11	-3	-14
Total Capital	- -	-173	-232	-62	-55	-108	-145	-158	-197	-196	-218	-242	-270
Total Debt/Capital (%)	- -	- -	- -	-29.51	-34.89	-17.83	-16.04	-17.33	-8.47	-4.85	-2.48	-2.23	-1.71
Total Debt / EV	- -	- -	- -	-0.54	-0.33	-1.89	1.9	-6.51	-0.64	-0.78	-0.48	-1.82	-0.33
EV/Sales	- -	- -	- -	1.28	1.99	0.76	- -	34.47	0.82	0.6	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	2	4	1	1	8	2	1	- -	- -	3
Diluted Enterprise Value	- -	-4	-5	11	16	-10	12	-4	-26	-12	-11	-3	-14
EV per Share	- -	- -	- -	290,840.51	619,527.56	351,776.8	2,446,747.2	1,100,249.93	67,387.2	9,377.58	293.14	30.18	- -
TTM Sales	- -	46	34	10	15	23	- -	4	12	3	- -	- -	- -
TTM EBITDA	-53	-49	-58	-64	-51	-49	-39	-26	-20	-28	-28	-24	-26
TTM Operating Income	-53	-51	-61	-68	-54	-52	-41	-27	-21	-29	-29	-25	-26
TTM Cash Flow to Firm	-51	-47	-49	-37	-42	-51	-42	-29	-22	-21	-12	-24	-26
TTM Free Cash Flow to Firm	-50	-46	-47	-34	-40	-50	-42	-29	-21	-21	-12	-24	-26

Multiples (USD)

API Chat

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	-0.06	-0.1	-0.02	-0.04	-0.29	-0.1	-0.04	-0.02	-0.01	-0.12
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	-4	-5	-34	-58	-10	12	-4	-26	-12	-11	-3	-14
Low Price	- -	- -	- -	770,369.6	523,213.2	505,982.4	223,361.6	95,863.2	207,732.8	63,166.4	4,939.4	73	1.04
EV/Sales	- -	- -	- -	1.28	1.99	0.76	- -	34.47	0.82	0.6	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	0.55	- -	- -	- -	- -	0.1	- -	- -	- -
Price/Earnings Average	- -	- -	- -	-0.02	0.3	-0.07	-0.05	-0.15	-0.2	0.19	-0.07	-0.24	-0.27
Price/Earnings High	- -	- -	- -	-0.07	0.59	-0.11	-0.11	-0.77	-0.4	0.38	-0.16	-1.34	-1.33
Price/Earnings Low	- -	- -	- -	-0.01	0.15	-0.02	-0.03	-0.04	-0.06	0.09	-0.01	-0.01	-0.01
Price/Book Value	- -	- -	- -	-0.03	-0.05	-0.01	-0.01	-0.05	-0.01	- -	- -	- -	-0.01
Price/Book Value Average	- -	- -	- -	-0.03	-0.03	-0.03	-0.01	-0.01	-0.03	-0.01	-0.01	-0.02	-0.03
Price/Book Value High	- -	- -	- -	-0.09	-0.06	-0.05	-0.03	-0.07	-0.05	-0.01	-0.01	-0.13	-0.13
Price/Book Value Low	- -	- -	- -	-0.02	-0.01	-0.01	-0.01	- -	-0.01	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	0.05	0.05	0.05	0.2	0.5	1.69	0.05	0.02	0.07	0.17
Price/Tangible Book Value Average	- -	- -	- -	0.06	0.03	0.15	0.27	0.17	4.77	0.09	0.1	1.23	0.4
Price/Tangible Book Value High	- -	- -	- -	0.17	0.05	0.23	0.61	0.82	9.26	0.17	0.23	6.81	1.99
Price/Tangible Book Value Low	- -	- -	- -	0.04	0.01	0.04	0.15	0.04	1.37	0.04	0.01	0.06	0.02
Price/Sales	- -	- -	- -	0.22	0.26	0.05	- -	1.94	0.17	0.27	- -	- -	- -
Price/Sales Average	- -	- -	- -	0.25	0.14	0.16	- -	0.64	0.47	0.49	- -	- -	- -
Price/Sales High	- -	- -	- -	0.76	0.28	0.25	- -	3.17	0.92	0.98	- -	- -	- -
Price/Sales Low	- -	- -	- -	0.15	0.07	0.04	- -	0.16	0.14	0.22	- -	- -	- -
Price/Cash Flow	- -	- -	- -	-0.06	-0.09	-0.02	-0.04	-0.28	-0.09	-0.04	-0.02	-0.01	-0.12
Price/Cash Flow Average	- -	- -	- -	-0.07	-0.05	-0.07	-0.05	-0.09	-0.27	-0.07	-0.11	-0.25	-0.27
Price/Cash Flow High	- -	- -	- -	-0.21	-0.1	-0.11	-0.11	-0.47	-0.52	-0.15	-0.24	-1.36	-1.35
Price/Cash Flow Low	- -	- -	- -	-0.04	-0.03	-0.02	-0.03	-0.02	-0.08	-0.03	-0.01	-0.01	-0.01
Price/Free Cash Flow Average	- -	- -	- -	-0.07	-0.05	-0.07	-0.05	-0.09	-0.28	-0.07	-0.11	-0.25	-0.27
Price/Free Cash Flow High	- -	- -	- -	-0.22	-0.1	-0.11	-0.11	-0.47	-0.54	-0.15	-0.24	-1.36	-1.35
Price/Free Cash Flow Low	- -	- -	- -	-0.04	-0.03	-0.02	-0.03	-0.02	-0.08	-0.03	-0.01	-0.01	-0.01
EV/Sales Average	- -	- -	- -	1.12	0.96	3.51	- -	9.38	6.53	4.63	- -	- -	- -
EV/Sales High	- -	- -	- -	1.63	1.1	5.78	- -	0.26	14.86	13.49	- -	- -	- -
EV/Sales Low	- -	- -	- -	1.03	0.89	0.6	- -	0.09	0.23	113.36	- -	- -	- -
EV/EBITDA Average	- -	0.07	0.08	-0.17	-0.28	0.16	-0.33	0.38	1.11	0.42	0.36	-0.1	0.39
EV/EBITDA High	- -	0.07	0.08	-0.25	-0.32	0.11	-0.4	-0.04	0.84	0.36	0.31	-1.2	-0.68
EV/EBITDA Low	- -	0.07	0.08	-0.16	-0.26	0.21	-0.31	0.46	1.32	0.45	0.4	0.12	0.64
EV/EBIT Average	- -	0.07	0.08	-0.16	-0.26	0.15	-0.31	0.36	1.05	0.4	0.35	-0.1	0.38
EV/EBIT High	- -	0.07	0.08	-0.24	-0.3	0.11	-0.37	-0.04	0.8	0.35	0.3	-1.18	-0.67
EV/EBIT Low	- -	0.07	0.08	-0.15	-0.24	0.2	-0.29	0.43	1.25	0.43	0.39	0.12	0.63
Last Price	- -	- -	- -	1,112,249.6	1,932,761.6	578,916.8	298,347.2	1,193,324	256,247.2	75,539.2	5,893.4	86.2	9.43
High Price	- -	- -	- -	3,778,913.6	2,051,280	2,894,584	911,680	1,953,600	1,406,917.6	278,371.8	84,004.8	7,992	109.8
Enterprise Value Average	- -	-4	-5	11	14	-8	13	-10	-23	-12	-10	3	-10
Enterprise Value High	- -	-4	-5	16	16	-6	15	1	-17	-10	-9	29	18
Enterprise Value Low	- -	-4	-5	10	13	-10	12	-12	-27	-12	-11	-3	-17

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	85,000	22,815,500	16,800,500	4,992,500	7,329,000	11,533,500	- -	615,571.43	1,536,500	283,090.91	- -	- -	- -
EBITDA per Share	-26,344,500	-24,735,500	-29,096,500	-32,199,000	-25,411,000	-24,637,500	-7,745,400	-3,726,857.14	-2,532,000	-2,521,818.18	-857,909.09	-5,986.18	-82.63
Operating Income per Share	-26,677,500	-25,746,000	-30,550,000	-33,880,000	-26,974,500	-25,832,500	-8,192,400	-3,927,714.29	-2,675,000	-2,603,727.27	-875,090.91	-6,073.07	-83.39
Basic EPS, GAAP	-26,668,500	-25,557,500	-29,658,500	-56,207,500	3,486,500	-26,844,500	-8,089,600	-2,535,714.29	-3,557,125	729,727.27	-527,606.06	-5,956.55	-82.3
Basic EPS from Cont Ops	-26,668,500	-25,557,500	-29,658,500	-59,945,500	-16,296,000	-26,844,500	-8,612,800	-4,417,571.43	-3,676,000	637,636.36	-565,151.52	-5,956.55	-82.3
Diluted EPS, GAAP	-26,668,500	-25,557,500	-29,658,500	-56,207,500	3,486,500	-26,844,500	-8,089,600	-2,535,714.29	-3,557,125	729,727.27	-527,606.06	-5,956.55	-82.3
Diluted EPS from Cont Ops	-26,668,500	-25,557,500	-29,658,500	-59,945,500	-16,296,000	-26,844,500	-8,612,800	-4,417,571.43	-3,676,000	637,636.36	-565,151.52	-5,956.55	-82.3
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-25,696,000	-23,503,500	-24,380,000	-18,431,000	-20,786,500	-25,711,000	-8,476,600	-4,188,285.71	-2,709,875	-1,911,090.91	-355,454.55	-5,871.39	-81.11
Free Cash Flow per Basic Share	-26,206,500	-23,998,000	-25,143,500	-19,687,000	-21,487,500	-26,199,000	-8,507,200	-4,200,857.14	-2,799,000	-1,913,727.27	-355,454.55	-5,871.39	-81.11
Cash & Equivalents per Share	- -	1,796,500	2,318,500	27,262,500	40,391,500	15,317,500	2,489,600	5,711,285.71	5,630,500	2,057,727.27	512,242.42	2,151.07	68.52
Book Value per Share	- -	-86,335,500	-115,994,000	-40,336,000	-36,848,500	-63,692,500	-33,562,200	-26,508,571.43	-26,752,000	-18,726,181.82	-6,769,272.73	-61,094.3	-871.54
Tangible Book Value per Share	- -	9,695,000	82,000	21,828,000	37,977,500	12,578,000	1,484,400	2,370,571.43	152,000	1,634,000	370,333.33	1,173.78	55.08

Aptevo Therapeutics Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)